|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Substance Abuse and Mental Health Services Administration. (2003). The DAWN report: Trends in drug-related emergency department visits, 1994-2001 at a glance. Available: http://dawninfo.samhsa.gov/pubs_94_02/shortreports/files/TDR_EDvisits_glance_1994_2001.pdf [November 7, 2003]. Swarns, R.L. (1998) Giuliani orders 5 city hospitals to wean addicts off methadone. New York Times, August 15. Terada, K., Niizuma, T., Ogita, S., and Kataoka, N. (2002). Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine. Vaccine, 20(31-32), 3638-3643. Thomas, C.P. (2000). No magic bullet: Adoption of naltrexone by clinical providers. Dissertation, Brandeis University. Thomas, C.P., and McCarty, D. (2004). Adoption of drug treatment technology in specialty and primary care settings. In H.J. Harwood and T.G. Myers (Eds.), New treatments for addiction: Behavioral, ethical, legal, and social questions. National Research Council and Institute of Medicine. Washington, DC: The National Academies Press. Thomas, C.P., Walack, S., Lee, S.S., McCarty, D., and Swift, R. (2003). Research to practice: Factors affecting the adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment, 24, 1-11. Thorndike, A.N., Biener, L., and Rigotti, N.A. (2002). Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. American Journal of Public Health, 92(3), 437-442. Tuncok, Y., Hieda, Y., Keyler, D.E., Brown, S., Ennifar, S., Fattom, A., and Pentel, P.R. (2001). Inhibition of nicotine-induced seizures in rats by combining vaccination against nicotine with chronic nicotine infusion. Experimental and Clinical Psychopharmacology, 9(2), 228-234. U.S. Department of Health and Human Services. (2000). Treating tobacco use and dependence. Washington, DC: U.S. Public Health Service. Villamor, N. (2003). Mechanism of action and resistance to monoclonal antibody therapy. Seminars in Oncology, 30(4), 424-433. Vizcarra, C. (2003). New perspectives and emerging therapies for immune-mediated inflammatory disorders. Journal of Infusion Nursing, 26(5), 319-325. von Sydow, K., Lieb, R., Pfister, H., Hofler, M., and Wittchen, H.U. (2002). What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults. Drug and Alcohol Dependence, 68(1), 49-64. Weissman, M. (2001). Stigma. Journal of the American Medical Association, 285, 261-262. Wilson, B. (1955). Alcoholics Anonymous: The story of how many thousands of men and women have recovered from alcoholism. New York: Alcoholics Anonymous. Woody, G.E. (2003). Treating dually diagnosed patients. Psychiatric Times, 20(1), 29-30. Woody, G.E., and McNichols, L. (2004). Putting addiction treatment medications to use: Lessons learned. In H.J. Harwood and T.G. Myers (Eds.), New treatments for addiction: Behavioral, ethical, legal, and social questions. National Research Council and Institute of Medicine. Washington, DC: The National Academies Press. World Health Organization. (2003). The history of vaccination. Available: http://www.who.int/vaccines-diseases/history/history.shtml [November 5, 2003].
|
|
|||||||||||||||
